Accordingly, Nbs with high affinity against SARS-CoV-2 S proteins, and the RBD could emerge as potential therapeutics in the fight against COVID-19, in line with the repertoire of potent neutralizing Nbs previously reported (Additional file 1: Table S5). The gene discussed is PROS1; the disease is COVID-19.